+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients

Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients

Strahlentherapie und Onkologie 179(4): 213-218

Background: Central neurocytomas are described as uncommon benign CNS lesions. Uncertainty exists about the most appropriate treatment regimen. This retrospective analysis compares four therapies for local control and overall survival: complete resection alone (KR), complete resection plus radiotherapy (KR-RT), incomplete resection alone (IR), and incomplete resection plus radiotherapy (ITR-RT). Material and Methods: The cases published in the literature since 1982 were reviewed for age, gender, extent of resection, atypical neurocytoma, radiotherapy, local control, and overall survival (minimum follow-up 12 months). From direct contact with the authors additional data were obtained providing more detailed information about the patients and a longer follow-up. Statistical analysis was performed with the Kaplan-Meier analysis and the log-rank test. Results: Complete data were obtained from 358 patients (KR 118, KR-RT 35, IR 91, IR-RT 114). Local control was significantly better after KR, KR-RT and IR-RT than after IR. No significant difference was found between KR, KR-RT and IR-RT. Median time to progression was 36 (KR), 39 (KR-RT), 21 (IR) and 32 (IR-RT) months. The comparison of the four groups for overall survival demonstrated that KR provided a significantly better overall survival than IR. Overall survival rates were 99.2% and 86.1%, respectively. Conclusions: Complete resection is much more effective for the treatment of central neurocytoma than incomplete resection. After complete resection the additional benefit of postoperative radiotherapy remains unclear. After incomplete resection postoperative radiotherapy significantly improved local control, but not overall survival.

(PDF same-day service: $19.90)

Accession: 035980191

Download citation: RISBibTeXText

PMID: 12707710

DOI: 10.1007/s00066-003-1061-9

Related references

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis. Annals of Oncology 26(7): 1305-1313, 2016

Meta-analysis comparing docetaxel and vinca-alkaloids in the first-line treatment of NSCLC. Comparison of results based on individual patient data, study report data, and published data. 2007

Clinical outcome and quality of life after treatment of patients with central neurocytoma. Neurosurgery Clinics of North America 26(1): 83-90, 2015

CISCA (cisplatin vs. carboplatin) meta-analysis: An individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology 24(18_suppl): 7011-7011, 2016

Predicting treatment failure with PPI-based triple therapies in metronidazole-resistant H pylori infections A model based on trial meta-analysis data. Gut. 45(suppl. 3): A118-A119,., 1999

Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circulation Research 116(8): 1346-1360, 2015

Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis. Oncotarget 9(12): 10272-10283, 2018

Comprehensive review of extraventricular neurocytoma with report of two cases, and comparison with central neurocytoma. Clinical Neuropathology 29(3): 134-140, 2011

Patterns of care and survival outcomes in patients with an extraventricular neurocytoma: An individual patient data analysis of 201 cases. Neurology India 66(2): 362-367, 2018

Real-world rates of hepatitis B surface antigen seroclearance in patients with chronic hepatitis B: a systematic review, conventional aggregated data meta-analysis and individual patient data meta-analysis. Journal of Hepatology 68: S478-S479, 2018

Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis. European Journal of Clinical Pharmacology 72(8): 933-944, 2016

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database of Systematic Reviews (): Cd007303-Cd007303, 2009

A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis. Methods of Information in Medicine 48(2): 104-112, 2009

Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation. Journal of Pharmacokinetics and Pharmacodynamics 37(2): 179-201, 2010

Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data. American Journal of Cardiovascular Drugs 16(6): 427-437, 2016